Advertisement

NLS Sweden

Clinical Trials - November 1, 2022

Gesynta Pharma prepares Phase II study of GS-248 in endometriosis

Gesynta Pharma has announced the decision to advance the development of its clinical-stage drug candidate GS-248 in endometriosis. This strategically important decision follows a recent preclinical proof-of-concept study with GS-248 in an advanced model of endometriosis, where disease-modifying properties of the drug candidate were firmly established, states the company in a press release. These data […]

Column - October 31, 2022

Commentary: Pandemic Preparedness

Staffan Svärd, Professor, Scientific Lead for SciLifeLab’s Pandemic Laboratory Preparedness Capability, writes about how lessons learned from the COVID-19 pandemic can increase our pandemic preparedness. Early in the pandemic, SciLifeLab, together with Knut and Alice Wallenberg Foundation, launched a major national COVID-19 research program. Today SciLifeLab has a government mandate to coordinate and expand the […]

Uncategorized - October 26, 2022

New Swedish Parkinson’s Disease clinical study approved

An investigational stem cell-based therapy for the treatment of Parkinson’s Disease, STEM-PD, has been given regulatory approval for a Phase I/IIa clinical trial. Ethical approval of the trial has already been obtained from the Swedish Ethics Review Authority, and the team, led from Lund University is thereby ready to proceed with the trial, they state. […]

Uncategorized - October 14, 2022

Strengthening Swedish collaboration in precision medicine

Genomic Medicine Sweden, GMS, has entered into an agreement with the Swedish life science sector’s trade associations to promote industry collaboration. The aim is to jointly strengthen national conditions for precision medicine. “For GMS, this agreement is a step towards creating improved and strengthened conditions for collaboration with industry. Through structured work, we will become […]

Uncategorized - October 14, 2022

A royal visit to SciLifeLab

SciLifeLab has welcomed their Majesties from the Netherlands and Sweden to learn more about technologies to study cells and initiatives for precision medicine. “It is a major recognition for SciLifeLab to be selected as a site for this state visit and it was our pleasure to guide these distinguished visitors through a glimpse of the […]

Uncategorized - September 28, 2022

New gene panel for solid tumors implemented in routine healthcare

Genomic Medicine Sweden (GMS) has developed a broad gene panel for solid tumors that facilitates detailed diagnostics for current and next generation targeted therapies. The new gene panel will be implemented in routine healthcare during the autumn. GMS’ working group for solid tumors has developed a gene panel that generates detailed molecular information from 560 […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.